新光药业股东和丰投资拟减持不超3%公司股份

Core Viewpoint - Shareholder He Feng Investment plans to reduce its stake in New Light Pharmaceutical by up to 4.8 million shares, representing no more than 3% of the company's total share capital [1] Group 1: Shareholder Information - He Feng Investment currently holds 25.181 million shares, which accounts for 15.74% of New Light Pharmaceutical's total share capital [1] - The reduction will occur within three months following a 15 trading day period from the announcement date [1] Group 2: Transaction Method - The share reduction will be executed through centralized bidding or block trading methods [1]